JustRaised: Funded Startup Founders Databasejustraised

Gabriel Mullokandov

Co-founder · Marrow Therapeutics

Biotechnology · Series A

Latest raise
$173M
Date raised
November 17, 2026
Round
Series A

About Gabriel Mullokandov

an experimental treatment for sickle cell disease and beta thalassemia that aims to deliver genetic medicines directly to bone marrow cells.

Who is Gabriel Mullokandov?
Gabriel Mullokandov is listed as Co-founder of Marrow Therapeutics, a biotechnology company.
How much did Marrow Therapeutics raise?
Marrow Therapeutics raised $173M in a Series A round on November 17, 2026 (5 days ago). Backed by Scion Life Sciences, venBio.

Get newly funded founders every week

A free weekly list of startups that just raised.

Request a custom lead list

Other recently funded founders